Frontier Medical Group has been acquired by Agilitas

Arrowpoint Advisory’s Management Advisory team has advised the management team of Frontier Medical Group on its sale to Agilitas.

Frontier Medical Group is a market leading group engaged in the manufacture and supply of Skin & Wound Care, Infection Control and Harm Reduction products to healthcare providers in the UK and internationally. Frontier Medical won the inaugural National BVCA “Responsible Portfolio Company Award” in 2017. Frontier Medical also won the award for “Business Transformation Management Team” at the BVCA Wales Management Team Awards 2019 and was included in The London Stock Exchange Group’s “1000 Companies to Inspire Britain 2019”, an annual celebration of some of the fastest-growing and most dynamic small and medium-sized enterprises in the UK. 

Kester Capital acquired Frontier Medical in 2013 and helped it to grow from a UK focused family-owned business into a leading manufacturer and supplier of Pressure Ulcer Prevention and Infection Prevention products to healthcare providers globally. During Kester Capital’s investment period, the Wales-headquartered business experienced significant international expansion and new product development, resulting in an increase of export revenues by 160% and total revenues by over 60%.

Cameron Crockett, Managing Partner of Kester Capital, commented: “We would like to thank the Frontier team, led by Simon Jackson, Matthew Bambery and Frank Collins, for their exceptional work over the last seven years. It has been a pleasure to partner with such an outstanding team and we wish them, the wider team and the business every success for the future.  It was very helpful to have the Arrowpoint Advisory team led by Simon and Jamie involved in the deal.  As experienced advisers they were able to help management through the process both in terms of negotiating their investment terms but also providing a good market perspective.”

Simon Jackson, CEO at Frontier Medical, added: “Kester Capital has been a great long-term partner and strong supporter of our ambitious plans. Together we have been able to achieve a great result for shareholders and most importantly a very favourable outlook for our business. The team at Arrowpoint Advisory’s experience and client focus were a huge help for us as we worked through the many complex work streams in the sale process.”

Simon Cope-Thompson, Managing Director, Arrowpoint Advisory, concluded: “We are delighted to have been able to help management on their deal with Agilitas. Having successfully grown the business in partnership with Kester they have built a great platform for further growth with their new private equity partners.

Contact the deal team